Home » QIAGEN Submits Companion Diagnostic, Investigational Lung Cancer Compound
QIAGEN Submits Companion Diagnostic, Investigational Lung Cancer Compound
Qiagen announced submission of its therascreen EGFR RGQ PCR Kit as a proposed companion diagnostic to guide treatment with afatinib, a new investigational oncology compound developed by Boehringer Ingelheim.
PR Newswire
PR Newswire
Upcoming Events
-
07May
-
14May
-
30May